SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-15-003890
Filing Date
2015-08-19
Accepted
2015-08-19 08:57:09
Documents
5
Period of Report
2015-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 58116
2 ex10-2.htm EX-10.2 146520
3 ex10-3.htm EX-10.3 134525
4 ex10-4.htm EX-10.4 148125
5 ex10-5.htm EX-10.5 146542
  Complete submission text file 0001493152-15-003890.txt   635334
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 151062971
SIC: 2834 Pharmaceutical Preparations